<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02985463</url>
  </required_header>
  <id_info>
    <org_study_id>2014-402M-MA-§ 23b MPG</org_study_id>
    <nct_id>NCT02985463</nct_id>
  </id_info>
  <brief_title>Left Atrial Appendage Occlusion and Biomarker Evaluation</brief_title>
  <acronym>LABEL</acronym>
  <official_title>Left Atrial Appendage Occlusion and Biomarker Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsmedizin Mannheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsmedizin Mannheim</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      &quot;Left Atrial Appendage Occlusion and Biomarker Evaluation&quot; (LABEL) is a single-center,&#xD;
      prospective and observational study evaluating changes of the expression of biomarkers in&#xD;
      eligible patients before and after percutaneous implantation of a left atrial appendage (LAA)&#xD;
      occlusion device at mid-term follow-up.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate the changes of different types of biomarkers before and after&#xD;
      successful percutaneous implantation of an LAA occlusion device.&#xD;
&#xD;
      Biomarker evaluation will focus on blood derived biomarkers including neurohormones,&#xD;
      proteins, cytokines, microRNAs and metabolomics.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 2014</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Biomarker levels before successful LAA occlusion device implantation</measure>
    <time_frame>24 hours before intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biomarker levels after successful LAA occlusion device implantation</measure>
    <time_frame>mid-term follow up at 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of biomarker expression before and after device implantation over mid-term follow-up, depending of complete, incomplete occlusion, imaging data (transesophageal echocardiography, computed tomography)</measure>
    <time_frame>mid-term follow up at 6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">60</enrollment>
  <condition>Stroke</condition>
  <condition>Atrial Fibrillation</condition>
  <condition>Bleeding</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Two peripheral blood withdraws in EDTA, citrate, ammonium heparin, serum tubes 24 hours&#xD;
      before and at mid-term follow up at 6 months after successful LAA occlusion device&#xD;
      implantation.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suffering from non valvular atrial fibrillation with a contraindication for oral&#xD;
        anticoagulation (i.e. bleeding) being eligible of percutaneous implantation of LAA&#xD;
        occlusion devices.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  non valvular atrial fibrillation, that makes anticoagulation to prevent embolic stroke&#xD;
             from the LAA&#xD;
&#xD;
          -  contraindication for the therapy with oral anticoagulants:&#xD;
&#xD;
          -  refusal to take oral anticoagulation&#xD;
&#xD;
          -  HasBled-score more than 3&#xD;
&#xD;
          -  prior bleedings under oral anticoagulation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  under 18 years&#xD;
&#xD;
          -  severely reduced left atrial function&#xD;
&#xD;
          -  mechanical heart valve&#xD;
&#xD;
          -  pulmonary embolism&#xD;
&#xD;
          -  deep vein thrombosis&#xD;
&#xD;
          -  myocardial infarction within the last 3 months&#xD;
&#xD;
          -  electrical cardioversion within 30 days after potential occluder implantation&#xD;
&#xD;
          -  atrial septum defect or interventional/surgical occlusion of ASD&#xD;
&#xD;
          -  status after heart transplant&#xD;
&#xD;
          -  symptomatic carotid artery stenosis&#xD;
&#xD;
          -  transient ischemic attack (TIA) or stroke within last 30 days&#xD;
&#xD;
          -  intracerebral bleeding within the last 2 months&#xD;
&#xD;
          -  acute infection&#xD;
&#xD;
          -  existing or planned pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ibrahim Akin, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>University Medical Center Mannheim</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Centre Mannheim</name>
      <address>
        <city>Mannheim</city>
        <state>Baden-Württemberg</state>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Behnes M, Akin I, Sartorius B, Fastner C, El-Battrawy I, Borggrefe M, Haubenreisser H, Meyer M, Schoenberg SO, Henzler T. --LAA Occluder View for post-implantation Evaluation (LOVE)--standardized imaging proposal evaluating implanted left atrial appendage occlusion devices by cardiac computed tomography. BMC Med Imaging. 2016 Mar 24;16:25. doi: 10.1186/s12880-016-0127-y.</citation>
    <PMID>27009279</PMID>
  </reference>
  <results_reference>
    <citation>Fastner C, Behnes M, Sartorius B, Yildiz M, Mashayekhi K, El-Battrawy I, Lehmann R, Baumann S, Becher T, Borggrefe M, Akin I. Left atrial appendage morphology, echocardiographic characterization, procedural data and in-hospital outcome of patients receiving left atrial appendage occlusion device implantation: a prospective observational study. BMC Cardiovasc Disord. 2016 Jan 28;16:25. doi: 10.1186/s12872-016-0200-z.</citation>
    <PMID>26822890</PMID>
  </results_reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>December 3, 2016</study_first_submitted>
  <study_first_submitted_qc>December 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2016</study_first_posted>
  <last_update_submitted>August 26, 2020</last_update_submitted>
  <last_update_submitted_qc>August 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsmedizin Mannheim</investigator_affiliation>
    <investigator_full_name>Michael Behnes</investigator_full_name>
    <investigator_title>Dr. med</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

